Invention Grant
- Patent Title: Antibodies against novel PD1 isoforms and uses thereof
-
Application No.: US16030180Application Date: 2018-07-09
-
Publication No.: US11236144B2Publication Date: 2022-02-01
- Inventor: Zhiwei Chen , Lin Cheng , Allen Ka Loon Cheung , Jingying Zhou
- Applicant: VERSITECH LIMITED
- Applicant Address: CN Hong Kong
- Assignee: VERSITECH LIMITED
- Current Assignee: VERSITECH LIMITED
- Current Assignee Address: CN Hong Kong
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Main IPC: C12N15/13
- IPC: C12N15/13 ; C07K16/28 ; C07K14/705 ; A61K39/00 ; A61K39/12
Abstract:
The present invention pertains to antibodies against a novel isoform of human PD1 protein (Δ42PD1) that contains a 42-nucleotide in-frame deletion in exon 2. The invention also pertains to methods of using the antibodies against Δ42PD1 for the treatment for autoimmune disorders. In certain embodiments, the antibodies against Δ42PD1 are monoclonal.
Public/Granted literature
- US20180312564A1 Antibodies Against Novel PD1 Isoforms and Uses Thereof Public/Granted day:2018-11-01
Information query
IPC分类:
